MedPath

Evaluation of CIED "Readers" for Disease Management

Completed
Conditions
Pacemaker Ddd
ICD
Interventions
Device: CIED interrogation
Registration Number
NCT03338946
Lead Sponsor
Edward Hospital
Brief Summary

The purpose of this study is to evaluate the use of remote interrogation (readers) of CIEDs in evaluation of suspected TIA/stroke patients, HF or those experiencing syncope. This approach has the potential to advance the practice of CIED evaluation by staff without specialized training in cardiac electrophysiology (non-EP staff). We hypothesize that actionable events will be identified with use of CIED readers. These events may include identification of atrial fibrillation in TIA/stroke patients, percentage biventricular pacing in patients with HF or evaluation of arrhythmic events in syncope patients. We believe that non-EP staff will find CIED readers easy or very easy to use and that time from transmission to analysis for non-EP trained staff will be low.

Detailed Description

Subjects with CIEDs undergoing evaluation for TIA/stroke, HF or syncope will be reviewed for inclusion/exclusion criteria. CIED interrogation, demographics and time of interrogation will be collected. Review of interrogation and medical record will be done to evaluate for actionable events including CIED programming, initiation or change in medications, admission/discharge or decision for further testing.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • have a Medtronic CIED compatible with Medtronic CareLink Express
  • being evaluated for heart failure, TIA/stroke or syncope
  • able to read and speak English
Exclusion Criteria

-CIED from other than Medtronic

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CIED subjectsCIED interrogationCIED interrogation
Primary Outcome Measures
NameTimeMethod
Incidence of actionable events after use of readers in suspected TIA/stroke, heart failure and syncopeone day

percent of those with events after reader review with actions such as admission/discharge, addition or change in medications, further testing

Secondary Outcome Measures
NameTimeMethod
Average number of minutes from transmission to analysisone day

number of minutes from CareLink Express interrogation to analysis

Trial Locations

Locations (1)

Edward Hospital

🇺🇸

Naperville, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath